Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GLENMARK PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
TEVA PHARMA
Dec-13
GLENMARK PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4873,479-   
Low Rs3493,022-   
Sales per share (Unadj.) Rs460.41,996.4-  
Earnings per share (Unadj.) Rs13.4124.7-  
Cash flow per share (Unadj.) Rs35.0286.1-  
Dividends per share (Unadj.) Rs2.50109.18-  
Avg Dividend yield %0.63.4 17.8%  
Book value per share (Unadj.) Rs335.12,217.6-  
Shares outstanding (eoy) m282.17848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.6 55.8%   
Avg P/E ratio x31.326.1 119.9%  
P/CF ratio (eoy) x11.911.4 105.0%  
Price / Book Value ratio x1.21.5 85.1%  
Dividend payout %18.787.5 21.4%   
Avg Mkt Cap Rs m117,9532,756,220 4.3%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m27,8100-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m129,9011,692,969 7.7%  
Other income Rs m3,1680-   
Total revenues Rs m133,0691,692,969 7.9%   
Gross profit Rs m15,125463,620 3.3%  
Depreciation Rs m6,113136,844 4.5%   
Interest Rs m3,49633,253 10.5%   
Profit before tax Rs m8,685293,523 3.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m4,911-3,584 -137.0%   
Profit after tax Rs m3,774105,758 3.6%  
Gross profit margin %11.627.4 42.5%  
Effective tax rate %56.5-1.2 -4,631.3%   
Net profit margin %2.96.2 46.5%  
BALANCE SHEET DATA
Current assets Rs m98,7371,143,425 8.6%   
Current liabilities Rs m50,455997,163 5.1%   
Net working cap to sales %37.28.6 430.2%  
Current ratio x2.01.1 170.7%  
Inventory Days Days791 7.4%  
Debtors Days Days11596 120.1%  
Net fixed assets Rs m76,920552,961 13.9%   
Share capital Rs m2824,167 6.8%   
"Free" reserves Rs m94,2810-   
Net worth Rs m94,5631,880,567 5.0%   
Long term debt Rs m38,521865,653 4.4%   
Total assets Rs m175,6583,868,976 4.5%  
Interest coverage x3.59.8 35.5%   
Debt to equity ratio x0.40.5 88.5%  
Sales to assets ratio x0.70.4 169.0%   
Return on assets %4.13.6 115.2%  
Return on equity %4.05.6 71.0%  
Return on capital %9.24.9 185.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,7510-   
CASH FLOW
From Operations Rs m6,254269,772 2.3%  
From Investments Rs m-5,285-95,591 5.5%  
From Financial Activity Rs m-775-323,609 0.2%  
Net Cashflow Rs m325-149,429 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare GLENMARK PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare GLENMARK PHARMA With: VIMTA LABS  RAYMED LABS  MEDICO REMEDIES   VIVO BIO TECH  AAYUSH FOOD & HERBS   



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.